Rybelsus - supply shortage

Resolved

semaglutide

Shortage information

The shortage affecting Rybelsus has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Rybelsus
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  semaglutide
• Therapeutic area (MESH):
  Diabetes Mellitus, Type 2
• Pharmaceutical forms affected:
  Tablet
• Strengths affected:
  • 3 mg
  • 7 mg
  • 14 mg
• Availability of alternatives:
  Yes

Key dates

• First published:
  11/07/2023
• Last updated:
  22/01/2024